Loading stock data…
Stepan Company (SCL)
$62.22-1.20 (-1.89%)
Market ClosedLast close Sep 8
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Stepan Company in the Basic Materials sector is trading at $62.22 with a market capitalization of $1.5B. Wall Street consensus targets $85.00 (1 analysts), implying a +36.6% move over the next 12 months. The stock is currently 9% below its 52-week high of $68.00, remaining 17.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +36.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $604.51M↑ | $553.89M↓ | $590.28M↓ | $594.69M |
| Gross Profit | — | $64.85M↑ | $51.52M↓ | $71.02M↓ | $71.89M |
| Operating Income | — | $15.82M↑ | $1.33M↓ | $21.79M↑ | $17.96M |
| Net Income | — | -$41.41M↓ | $5.00M↓ | $10.84M↓ | $11.34M |
Peer Comparison
Fundamentals
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and international...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.48B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.94
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.53%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.14%
Volume
Today's trading volume
119,826
Recent News
Stepan Eyes Margin Recovery as Catalyst Targets $100M in Savings
Stepan (NYSE:SCL) is in the early stages of a margin recovery, supported by growth in higher-margin product areas, cost reductions and broader-based volume gains, Chief Financial Officer Ruben Velasquez said during a company presentation. Velasquez said second-quarter EBITDA increased 45% year over
Are Options Traders Betting on a Big Move in Stepan Stock?
Investors need to pay close attention to SCL stock based on the movements in the options market lately.
Stepan (SCL) Q2 2026 Earnings Call Transcript
Adjusted net income more than doubled on volume growth and margin recovery.
Stepan (SCL) Posts Stronger Q2 Results And Affirms Dividend, Does The Stock Still Look Cheap?
Why Stepan Stock Is In Focus After Earnings, Governance Moves, and Dividend Update Stepan (SCL) is back on investor radars after the company reported stronger second quarter results, announced board and executive changes, and reaffirmed its quarterly cash dividend on July 29, 2026. See our latest analysis for Stepan. Stepan's recent governance changes and dividend affirmation have come alongside strong momentum in the share price, with a 30-day share price return of 13.18% and a year to date...
Is Stepan’s (SCL) Dividend Amid a Half-Year Loss Reframing Its Investment Narrative?
Stepan Company recently reported that for the second quarter ended June 30, 2026, sales rose to US$684.11 million and net income to US$22.91 million, while also declaring a quarterly dividend of US$0.395 per share payable on September 15, 2026, and announcing several board and senior accounting leadership changes. An interesting nuance is that despite the stronger quarter, Stepan still reported a six‑month net loss of US$18.50 million, highlighting that the apparent improvement is emerging...